- Accession Number
Drug Drug Description Inolimomab Inolimomab is under investigation as an agent to treat steroid-resistant graft vs host disease. It has thus far offered similar efficacy to other monoclonal antibody options, though it may carry...
- Drugs & Drug Targets
Drug Target Type Inolimomab Interleukin-2 receptor subunit alpha target